- Home
- HUIZ vs RFL Comparison
HUIZ vs RFL Comparison
Compare HUIZ & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | HUIZ | RFL |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Real Estate |
| Sector | Finance | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.5M | 61.1M |
| IPO Year | 2019 | 2017 |
Fundamental Metrics
Financial Performance| Metric | HUIZ | RFL |
|---|---|---|
| Price | $1.70 | $1.26 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.30 | N/A |
| AVG Volume (30 Days) | 6.4K | ★ 104.9K |
| Earning Date | 03-27-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.28 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $917,000.00 |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $8.55 | N/A |
| P/E Ratio | $7.81 | ★ N/A |
| Revenue Growth | N/A | ★ 43.96 |
| 52 Week Low | $1.50 | $1.12 |
| 52 Week High | $4.16 | $3.19 |
Technical Indicators
Market Signals| Indicator | HUIZ | RFL |
|---|---|---|
| Relative Strength Index (RSI) | 41.49 | 46.39 |
| Support Level | $1.60 | $1.15 |
| Resistance Level | $2.19 | $1.32 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 24.48 | 19.94 |
Price Performance
Historical ComparisonAbout HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About RFL Rafael Holdings Inc. Class B
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.